- Home
- / NxStage Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NxStage Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$393.9 M
FY, 2017
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 217.3M | 242.1M | 263.4M | 301.5M | 336.1M | 366.4M | 393.9M |
| Revenue growth, % | 14.5% | 11.5% | 9.0% | ||||
| Cost of goods sold | 139.6M | 149.3M | 160.9M | 185.6M | 204.7M | 214.4M | 225.7M |
| Gross profit | 77.6M | 92.8M | 102.5M | 115.9M | 131.5M | 152.0M | 168.3M |
| Gross profit margin, % | 35.7% | 38.3% | 38.9% | 38.4% | 39.1% | 41.5% | 42.7% |
| General and administrative expense | 23.2M | 27.5M | 32.3M | 34.1M | 35.1M | 32.8M | 41.8M |
| Operating expense total | 93.1M | 104.0M | 120.3M | 138.1M | 146.1M | 156.3M | 182.1M |
| EBIT | (15.5M) | (11.2M) | (17.8M) | (22.2M) | (14.6M) | (4.3M) | (13.9M) |
| EBIT margin, % | -7.1% | -4.6% | -6.8% | -7.4% | -4.4% | -1.2% | -3.5% |
| Interest income | 4.0K | ||||||
| Interest expense | 4.7M | 2.8M | 611.0K | 863.0K | 1.1M | 1.0M | 756.0K |
| Pre tax profit | (20.5M) | (14.1M) | (18.8M) | (23.1M) | (15.2M) | (6.2M) | (15.5M) |
| Income tax expense | 899.0K | 1.0M | (245.0K) | 1.3M | 1.1M | 1.1M | (145.0K) |
| Net Income | (21.4M) | (15.2M) | (18.6M) | (23.9M) | (15.3M) | (4.8M) | (14.0M) |